Quinn Snyder graduated from the University of Arizona College of Medicine in 2007. In 2010, after studying under Andrew Weil and traveling to India to study plant-based medicines, he completed his residency in Emergency Medicine at Drexel University.
Dr. Snyder founded Kadelyx in 2024, devoting his clinical practice primarily to exploring ketamine for psychotherapeutic purposes. Quinn is a member of the American Society of Ketamine Practitioners. He has used Ketamine safely and continuously in clinical practice through his entire career and is committed to the emerging field of psychedelic medicines for healing.
Quinn has continuously practiced EM at some of the top Departments in the Phoenix Metro Area and is a 2025 Phoenix Magazine Top Doc. During the pandemic, he oversaw the clinical operations of the largest Emergency Department in Arizona. His experience was the subject of interviews on CNN, PBS Newshour, BBC World News, NPR, The Washington Post, and The Guardian.
Michael B, Patient
Aytan D, Patient
Kathryn A, Patient
